YOLFTbeta
Xlife Sciences AG

Xlife Sciences AG

XLS · SW · Healthcare / Biotechnology

8.48CHF-0.08 (-0.93%)

Price History

Full chart

Market Stats

Previous Close8.56
Open8.46
Day Range8.46 – 8.56
52-Week Range9.34 – 26.80
Volume577
Market Cap54.21M
P/E (TTM)0.00
Forward P/E0.00
EPS-32.31
Dividend Yield0.00%
Beta0.50
50-Day Avg13.90
200-Day Avg19.76

About

Xlife Sciences AG focuses on the development and commercialization of research projects in the life sciences sector. The company's project covers technology platforms, biotechnology/therapies, medical technology, and artificial intelligence/digital health areas that focuses on identifying new therapeutic approaches and biomarkers for common diseases based on human genetic data; and offers clinical research services. It also develops novel treatment options in specific indication areas; focuses in the areas of medical technology to develop innovative methods for diagnosing illnesses and/or patient monitoring; and deploys artificial intelligence to improve diagnostic methods and/or processes in the field of biotechnology. Xlife Sciences AG was founded in 2019 and is headquartered in Zurich, Switzerland.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Oliver R. Baumann
  • Employees20
  • HeadquartersTalacker 35, Zurich, Switzerland, 8001, Switzerland
  • Websitehttps://www.xlifesciences.ch

Leadership

  • Mr. Oliver R. BaumannCEO & Executive Director · b. 1988
  • Mr. Carl von HalemChief Financial Officer
  • Mr. Beat KlauiHead of Accounting & Taxation
  • Dr. Alexander ZinkChief Scientific Officer
  • Dr. Dennis FinkSenior Communications & Investor Relations Manager
  • Mr. Christian FaberHead of Legal & Compliance
  • Dr. Frank PlogerManaging Director of Xlife Sciences USA

Financials

Income Statement

Currency: CHF2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue514.83K396.81K806.07K1.03M988.44K834.88K275.31K
Growth (%)--22.92%+103.14%+27.53%-3.85%-15.54%-67.02%
Cost of Revenue335.84K422.41K446.95K842.33K539.42K285.35K265.99K
Gross Profit178.99K-25.60K359.12K185.64K449.02K549.53K9.32K
Gross Margin34.77%-6.45%44.55%18.06%45.43%65.82%3.39%
Operating Expense946.80K3.07M5.59M21.17M20.76M19.90M31.57M
Operating Income-767.81K-3.09M-5.23M-20.98M-20.31M-19.35M-31.56M
Operating Margin-149.14%-779.55%-649.20%-2041.20%-2054.54%-2317.27%-11462.00%
EBITDA---20.75M20.95M40.50M-3.05M
EBITDA Margin---2018.42%2119.44%4851.25%-1108.86%
Net Income1.05M21.46M53.42M14.31M14.88M34.28M-21.55M
Net Income Margin203.99%5408.40%6627.03%1392.26%1505.33%4105.60%-7826.48%
R&D-79.89K228.21K144.72K250.91K15.58K0
R&D as % of Total Revenue-20.13%28.31%14.08%25.38%1.87%0.00%
Interest Expense-180.78K495.18K687.47K385.03K473.17K448.71K
Interest Expense % of Total Revenue-45.56%61.43%66.88%38.95%56.68%162.98%

Balance Sheet

Currency: CHF2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets154.02M185.68M480.06M490.23M511.99M540.37M517.12M
Total Liabilities56.64M55.51M268.83M255.00M243.82M235.11M144.76M
Total Equity97.38M130.17M211.23M235.23M268.17M305.26M286.53M
Cash-4.70M1.96M221.03K218.71K99.03K404.41K
Net Debt-47.52M61.01M60.02M56.20M59.04M59.48M

Cash Flow

Currency: CHF2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-398.24K-401.55K-4.32M-4.61M171.78K-421.51K-903.00K
Investing Cash Flow-5.29M-3.86M-7.03M-1.68M-1.01M-4.00M-
Financing Cash Flow8.22M6.43M8.60M4.56M828.55K4.30M-
Capital Expenditure24.93K222.19K1.21M80.16K41.08K12.09K372.20K
Free Cash Flow--623.74K-5.54M-4.69M130.70K-433.60K-1.28M
FCF to OCF-155.33%128.03%101.74%76.09%102.87%141.22%

Earnings

Report DateJun 10, 2020Dec 29, 2020Apr 26, 2021Aug 10, 2021Jun 30, 2022Sep 28, 2022Apr 20, 2023Sep 18, 2024Apr 25, 2025Sep 23, 2025
EPS Estimate0.000.000.000.000.000.00-0.000.00-
EPS Actual0.30-0.042.420.887.07-1.482.360.084.46-0.53
Surprise----------
Timing---After-hoursPre-marketAfter-hoursPre-market--Pre-market

Key Statistics & Ratios

Market Cap54.21M
Enterprise Value131.05M
Trailing P/E0.00
Forward P/E0.00
Price / Sales136.47
Price / Book0.25
EPS-32.31
Book Value50.25
Revenue (TTM)397.23K
Gross Profit (TTM)217.58K
EBITDA-3.22M
Profit Margin0.00%
Operating Margin-1962.95%
Return on Equity-64.12%
Return on Assets-4.45%
Shares Outstanding5.77M
Shares Float2.90M
Beta0.50
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%